Your browser doesn't support javascript.
loading
Vpr is preferentially targeted by CTL during HIV-1 infection.
Altfeld, M; Addo, M M; Eldridge, R L; Yu, X G; Thomas, S; Khatri, A; Strick, D; Phillips, M N; Cohen, G B; Islam, S A; Kalams, S A; Brander, C; Goulder, P J; Rosenberg, E S; Walker, B D.
Affiliation
  • Altfeld M; Partners AIDS Research Center and Infectious Disease Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
J Immunol ; 167(5): 2743-52, 2001 Sep 01.
Article in En | MEDLINE | ID: mdl-11509618
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / HIV Infections / HIV-1 / Gene Products, vpr Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: J Immunol Year: 2001 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / HIV Infections / HIV-1 / Gene Products, vpr Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: J Immunol Year: 2001 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos